Complaint Filed In Court Against 3 Pharma Companies

Chandigarh : The Drug Controller Office, UT, has filed a case in a local court against the directors and other officials of a Parwanoo-based pharmaceutical company and two local firms for allegedly manufacturing and selling substandard and spurious drugs.

The complaint case against the manufacturing company, M/s Real Care Lifesciences, Parwanoo, and dealers Biomorph Lifesciences Limited and Zonex Healthcare has been filed under Sections 16-A, 17-B and 18-A of the Drugs and Cosmetics Act.

As per the complaint, the Drug Controller Office took samples of three drugs used for the treatment of pain and fever, which were manufactured by the Parwanoo company, from Biomorph Lifesciences. The reports of the samples revealed that the drugs were substandard.

In samples of one of the drugs, the contents of two components were found zero per cent. The samples of the other two drugs were also found substandard.

After receiving reports from the laboratory, the Drug Controller Office issued notices to Biomorph Lifesciences. In its reply, the firm informed that it had procured the drugs from Zonex Healthcare.

In its reply, Zonex Healthcare stated that the drugs were supplied by M/s Real Care Lifesciences. Issuing the notices to the three firms, the court has adjourned the hearing in the case to December 5 this year.

  • Related Posts

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    The ministry of health and family welfare has declared the Pharmacy Council of India’s (PCI) recently notified regulation on the pharmacist recruitment, promotion and services as ultra vires and does…

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    NAIROBI/GENEVA— In an alarming development that underscores the accelerating global crisis of antimicrobial resistance, researchers have confirmed the detection of a rare, pan-drug resistant strain of the high-priority fungal pathogen…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications